Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SNTA > SEC Filings for SNTA > Form 8-K on 21-Jul-2014All Recent SEC Filings

Show all filings for SYNTA PHARMACEUTICALS CORP

Form 8-K for SYNTA PHARMACEUTICALS CORP


21-Jul-2014

Other Events, Financial Statements and Exhibits


ITEM 8.01 Other Events.

On July 21, 2014, Synta Pharmaceuticals Corp. issued a press release announcing the advancement of ganetespib into the Phase 3 extension of the AML LI- (less intensive)-1 trial. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.



ITEM 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit
Number               Description

99.1      Press Release, dated July 21, 2014


  Add SNTA to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SNTA - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.